封面
市場調查報告書
商品編碼
1421658

尿路結石管理設備市場、份額、規模、趨勢、行業分析報告:按治療類型、最終用途、地區、細分市場、預測,2023-2032 年

Urolithiasis Management Devices Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy); By End-use; By Region, And Segment Forecasts, 2023 - 2032

出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究,到 2032 年,全球尿路結石治療設備市場規模預計將達到 35.1 億美元。 該研究報告提供了對當前市場動態的詳細洞察,並對未來市場成長進行了分析。

尿路結石盛行率的不斷上升促使治療方案不斷進步。 根據歐洲泌尿外科協會的數據,尿路結石是一種與生活方式相關的疾病,盛行率為 10%,需要係統性的治療方法。 尿石症是指泌尿系統中結石的形成,包括腎臟、輸尿管和膀胱。 在美國、加拿大和德國,這是一個重要的醫療保健問題,大多數情況下復發率接近 50%。

尿石症可以透過改變生活方式、飲食管理和基本藥物來控制,但清除引起劇烈疼痛的大結石需要多種治療方法。 根據結石的大小、位置和解剖變化,有侵入性和非侵入性碎石技術。

最近的研究表明,無論性別如何,腎結石的盛行率已增加到大約十分之一。 此外,這些患者中有一半可能在一生中經歷多次有症狀的腎結石。 稱為巨噬細胞的發炎細胞會影響腎結石從前驅物的發展。 最近的一項研究表明,與對照組相比,在出現有臨床意義的結石的患者中,腎臟中鈣沉積量的增加導致發炎巨噬細胞的活化。

體內碎石術使用內視鏡識別結石並將其分解成更小的碎片。 超音波和雷射等技術用於分解結石,使較小的碎片能夠通過泌尿系統。 由於其在實現無結石狀態方面的高效性,體內碎石術預計將成為預測期內的首選治療選擇。 此外,經皮腎鏡取石術是一種在體外或體內碎石術無效時用於去除較大結石的外科手術,通常需要住院一週。

先進手術技術(如內視鏡)和微型配件(如導絲、手術刀和籃子)的引入,使得微創手術得以在短時間內有效地從泌尿系統中取出結石。改善了。

尿路結石管理設備市場報告亮點

  • 2022年,體內碎石術因其效率高且最適合男性腎結石而佔據最大的市場份額。
  • 由於醫院成本上升和住院時間縮短,體內碎石領域佔據了最大的市場份額。
  • 在腎結石病例上升、手術介入和消費者意識的推動下,北美地區將在 2022 年佔據最大的市場份額。
  • 主要市場參與者包括 Cook Medical、ConMed、DirexGroup、Dornier MedTech、KARL STORZ、Olympus、Richard Wolf 和 Siemens Healthcare。

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章研究方法

第 4 章全球尿路結石治療設備市場洞察

  • 尿路結石管理設備市場 - 產業概況
  • 尿路結石治療設備的市場動態
    • 促進因素和機會
      • 肥胖發生率增加
      • 人口老化加劇
    • 抑制因素和挑戰
      • 治療費用高
  • PESTLE分析
  • 泌尿道結石管理設備的產業趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章全球尿路結石治療設備市場(依治療類型)

  • 主要發現
  • 簡介
  • 體外震波碎石術 (ESWL)
  • 內碎石術
  • 經皮腎鏡取石術
  • 其他

第 6 章全球尿路結石治療設備市場(依最終用途)

  • 主要發現
  • 簡介
  • 醫院和診所
  • 日間手術中心 (ASC)

第 7 章全球尿路結石治療設備市場(按地區)

  • 主要發現
  • 簡介
    • 2019-2032 年尿路結石管理設備市場評估,地區
  • 尿路結石治療設備市場 - 北美
    • 北美:尿路結石管理設備市場,依最終用途,2019-2032 年
    • 北美:尿路結石管理設備市場,依治療類型,2019-2032 年
    • 尿路結石治療設備市場 - 美國
    • 尿路結石管理設備市場 - 加拿大
  • 尿路結石治療設備市場 - 歐洲
    • 歐洲:尿路結石管理設備市場,依最終用途,2019-2032 年
    • 歐洲:尿路結石管理設備市場,依治療類型,2019-2032 年
    • 尿路結石管理設備市場 - 英國
    • 尿路結石治療設備市場 - 法國
    • 尿路結石治療設備市場 - 德國
    • 尿路結石治療設備市場 - 義大利
    • 尿路結石治療設備市場 - 西班牙
    • 尿路結石治療設備市場 - 荷蘭
    • 尿路結石治療設備市場 - 俄羅斯
  • 尿路結石治療設備市場 - 亞太地區
    • 亞太地區:尿路結石管理設備市場,依最終用途,2019-2032 年
    • 亞太地區:尿路結石管理設備市場,依治療類型,2019-2032 年
    • 尿路結石治療設備市場 - 中國
    • 尿路結石治療設備市場 - 印度
    • 尿路結石治療設備市場 - 馬來西亞
    • 尿路結石治療設備市場 - 日本
    • 尿路結石治療設備市場 - 印度尼西亞
    • 尿路結石治療設備市場 - 韓國
  • 尿路結石管理設備市場 - 中東和非洲
    • 中東和非洲:2019-2032 年尿路結石管理設備市場,依最終用途
    • 中東和非洲:尿路結石管理設備市場,按治療類型,2019-2032 年
    • 尿路結石治療設備市場 - 沙烏地阿拉伯
    • 尿路結石治療設備市場 - 阿拉伯聯合大公國
    • 尿路結石治療設備市場 - 以色列
    • 尿路結石管理設備市場 - 南非
  • 尿路結石管理設備市場 - 拉丁美洲
    • 拉丁美洲:尿路結石管理設備市場,以最終用途,2019-2032 年
    • 拉丁美洲:尿路結石管理設備市場,依治療類型,2019-2032 年
    • 尿路結石治療設備市場 - 墨西哥
    • 尿路結石治療設備市場 - 巴西
    • 尿路結石治療設備市場 - 阿根廷

第 8 章競爭態勢

  • 擴張與收購分析
    • 擴大
    • 收購
  • 夥伴關係/協作/協議/揭露

第 9 章公司簡介

  • Allengens
  • Boston Scientific
  • BD
  • Cook Medical
  • ConMed
  • DirexGroup
  • Dornier MedTech
  • KARL STORZ
  • Potent Optotronic
  • HealthTronics
  • Lumenis
  • Olympus
  • Richard Wolf
  • Siemens Healthcare
Product Code: PM3989

The global urolithiasis management devices market size is expected to reach USD 3.51 billion by 2032, according to a new study by Polaris Market Research. The report "Urolithiasis Management Devices Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy), By End-use, By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising incidence of urinary stones has driven advancements in treatment options. According to the European Association of Urology, it is a prevalent lifestyle disorder with a 10% prevalence rate, necessitating a systematic treatment approach. Urolithiasis refers to the formation of stones in the urinary system, including the kidneys, ureters, & bladder. It poses a significant healthcare concern in the U.S., Canada, & Germany, with a recurrence rate of nearly 50 percent in most of the cases.

While lifestyle changes, controlled diet, and basic medication can manage urolithiasis, various treatment approaches are required for the removal of large stones causing severe pain. Depending on the stone size, location, & anatomical variations, both invasive & non-invasive stone procedures are available.

Kidney stone disease is a prevalent urologic condition among adults in the U.S. Recent studies indicate that the prevalence of kidney stones has risen to approximately 1 in 10 individuals of all genders. Additionally, half of these individuals are likely to experience multiple symptomatic kidney stones throughout their lives. Inflammatory cells called macrophages influence the development of kidney stones from precursor materials. A recent study indicated that elevated calcium deposits in the kidney led to the activation of proinflammatory macrophages in patients who developed clinically significant stones, contrasting with the control group.

Intracorporeal lithotripsy treatments involve identifying and breaking down stones into smaller fragments using endoscopy. Techniques like ultrasound or laser are employed to disintegrate stones, allowing the passage of smaller pieces through the urinary system. Due to its high effectiveness in achieving a stone-free state, intracorporeal lithotripsy is expected to be a preferred treatment option in the forecast period. Additionally, percutaneous nephrolithotomy is a surgical method used for removing larger stones when extracorporeal or intracorporeal lithotripsies are ineffective, typically requiring a week-long hospital stay.

The introduction of advanced surgical technologies like endoscopy and micro accessories such as guidewires, scalpels, and baskets has significantly improved the acceptance of minimally invasive surgeries for efficiently removing stones from the urinary system within a short timeframe.

Urolithiasis Management Devices Market Report Highlights

  • In 2022, the intra-corporeal lithotripsy segment held the largest market share, as its high efficiency rate, and most suitable for renal stones in men
  • The intra-corporeal lithotripsy segment held the largest market share, on account for rising hospitals costs, and shortened hospital stays.
  • In 2022, North America region dominated the largest market share, rising cases of renal stones, surgical interventions, and awareness among consumer
  • The key market players include Cook Medical, ConMed, DirexGroup, Dornier MedTech, KARL STORZ, Olympus, Richard Wolf, and Siemens Healthcare.

Polaris Market Research has segmented the Urolithiasis management devices market report based on treatment type, end use, and region:

Urolithiasis Management Devices, Treatment Type Outlook (Revenue - USD Billion, 2023 - 2032)

  • Extracorporeal Shock Wave Lithotripsy (ESWL)
  • Intracorporeal Lithotripsy
  • Percutaneous Nephrolithotomy
  • Others

Urolithiasis Management Devices, End Use Outlook (Revenue - USD Billion, 2023 - 2032)

  • Hospitals & Clinics
  • Ambulatory Surgical Centers (ASCs)

Urolithiasis Management Devices, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Urolithiasis Management Devices Market Insights

  • 4.1. Urolithiasis Management Devices Market - Industry Snapshot
  • 4.2. Urolithiasis Management Devices Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing incidence of obesity
      • 4.2.1.2. Increasing Aging Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Treatment Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Urolithiasis Management Devices Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Urolithiasis Management Devices Market, by Treatment Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Urolithiasis Management Devices, by Treatment Type, 2019-2032 (USD Billion)
  • 5.3. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 5.3.1. Global Urolithiasis Management Devices Market, by Extracorporeal Shock Wave Lithotripsy (ESWL), by Region, 2019-2032 (USD Billion)
  • 5.4. Intracorporeal Lithotripsy
    • 5.4.1. Global Urolithiasis Management Devices Market, by Intracorporeal Lithotripsy, by Region, 2019-2032 (USD Billion)
  • 5.5. Percutaneous Nephrolithotomy
    • 5.5.1. Global Urolithiasis Management Devices Market, by Percutaneous Nephrolithotomy, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Urolithiasis Management Devices Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Urolithiasis Management Devices Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • 6.3. Hospitals & Clinics
    • 6.3.1. Global Urolithiasis Management Devices Market, by Hospitals & Clinics, by Region, 2019-2032 (USD Billion)
  • 6.4. Ambulatory Surgical Centers (ASCs)
    • 6.4.1. Global Urolithiasis Management Devices Market, by Ambulatory Surgical Centers (ASCs), by Region, 2019-2032 (USD Billion)

7. Global Urolithiasis Management Devices Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Urolithiasis Management Devices Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Urolithiasis Management Devices Market - North America
    • 7.3.1. North America: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.3.2. North America: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.3.3. Urolithiasis Management Devices Market - U.S.
      • 7.3.3.1. U.S.: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.3.4. Urolithiasis Management Devices Market - Canada
      • 7.3.4.1. Canada: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.4. Urolithiasis Management Devices Market - Europe
    • 7.4.1. Europe: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.3. Urolithiasis Management Devices Market - UK
      • 7.4.3.1. UK: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.4. Urolithiasis Management Devices Market - France
      • 7.4.4.1. France: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.5. Urolithiasis Management Devices Market - Germany
      • 7.4.5.1. Germany: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.6. Urolithiasis Management Devices Market - Italy
      • 7.4.6.1. Italy: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.7. Urolithiasis Management Devices Market - Spain
      • 7.4.7.1. Spain: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.8. Urolithiasis Management Devices Market - Netherlands
      • 7.4.8.1. Netherlands: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.9. Urolithiasis Management Devices Market - Russia
      • 7.4.9.1. Russia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.5. Urolithiasis Management Devices Market - Asia Pacific
    • 7.5.1. Asia Pacific: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.3. Urolithiasis Management Devices Market - China
      • 7.5.3.1. China: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.4. Urolithiasis Management Devices Market - India
      • 7.5.4.1. India: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.5. Urolithiasis Management Devices Market - Malaysia
      • 7.5.5.1. Malaysia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.6. Urolithiasis Management Devices Market - Japan
      • 7.5.6.1. Japan: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.7. Urolithiasis Management Devices Market - Indonesia
      • 7.5.7.1. Indonesia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.8. Urolithiasis Management Devices Market - South Korea
      • 7.5.8.1. South Korea: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.6. Urolithiasis Management Devices Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.3. Urolithiasis Management Devices Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.4. Urolithiasis Management Devices Market - UAE
      • 7.6.4.1. UAE: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.5. Urolithiasis Management Devices Market - Israel
      • 7.6.5.1. Israel: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.6. Urolithiasis Management Devices Market - South Africa
      • 7.6.6.1. South Africa: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.7. Urolithiasis Management Devices Market - Latin America
    • 7.7.1. Latin America: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.7.3. Urolithiasis Management Devices Market - Mexico
      • 7.7.3.1. Mexico: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.7.4. Urolithiasis Management Devices Market - Brazil
      • 7.7.4.1. Brazil: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.7.5. Urolithiasis Management Devices Market - Argentina
      • 7.7.5.1. Argentina: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Allengens
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Boston Scientific
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. BD
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Cook Medical
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. ConMed
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. DirexGroup
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Dornier MedTech
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. KARL STORZ
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Potent Optotronic
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. HealthTronics
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Lumenis
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Olympus
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Richard Wolf
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Siemens Healthcare
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development

List of Tables

  • Table 1 Global Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 2 Global Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 3 Urolithiasis Management Devices Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 5 North America: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 7 U.S.: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 9 Canada: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 11 Europe: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 12 UK: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 13 UK: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 14 France: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 15 France: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 17 Germany: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 19 Italy: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 21 Spain: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 25 Russia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 28 China: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 29 China: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 30 India: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 31 India: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 35 Japan: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 39 South Korea: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 45 UAE: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 47 Israel: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 49 South Africa: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 51 Latin America: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 53 Mexico: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 55 Brazil: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Urolithiasis Management Devices Market, by End Use, 2019-2032 (USD Billion)
  • Table 57 Argentina: Urolithiasis Management Devices Market, by Treatment Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Urolithiasis Management Devices Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End Use
  • Figure 7 Global Urolithiasis Management Devices Market, by End Use, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Treatment Type
  • Figure 9 Global Urolithiasis Management Devices Market, by Treatment Type, 2022 & 2032 (USD Billion)
  • Figure 10 Urolithiasis Management Devices Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Urolithiasis Management Devices Market